Subcutaneous immunotherapy (SCIT)

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Xu Yu

Conditions

Allergic RhinitisRhinitis, Allergic, Seasonal

Phase 2

Long-Term Effects of Sublingual Grass Therapy

CompletedNCT01335139

National Institute of Allergy and Infectious Diseases (NIAID)Rhinitis, Allergic, Seasonal

Start: 2011-03-31End: 2015-02-28Updated: 2017-06-02

Unknown Phase

Intratonsillar Immunotherapy for Allergic Rhinitis

RecruitingNCT06523478

Xu YuAllergic Rhinitis

Start: 2024-04-29End: 2028-04-29Target: 120Updated: 2024-07-26

Related Papers

Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.

2023-07-1510 citations

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

2017-02-01151 citations